Rankings
▼
Calendar
FATE FY 2023 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FATE
Fate Therapeutics, Inc.
$158M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$64M
-34.0% YoY
Gross Profit
-$94M
-147.4% margin
Operating Income
-$191M
-299.9% margin
Net Income
-$161M
-253.3% margin
EPS (Diluted)
$-1.64
Cash Flow
Operating Cash Flow
-$132M
Free Cash Flow
-$138M
Stock-Based Comp.
$43M
Balance Sheet
Total Assets
$506M
Total Liabilities
$138M
Stockholders' Equity
$368M
Cash & Equivalents
$42M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$96M
-34.0%
Gross Profit
-$94M
$83M
-213.5%
Operating Income
-$191M
-$308M
+38.2%
Net Income
-$161M
-$282M
+42.9%
← Q4 2022
All Quarters
Q1 2023 →